User profiles for Jonathan G. Braun
 | Jonathan BraunInflammatory Bowel and Immmunobiology Research Institute, Cedars Sinai Medical Center Verified email at cshs.org Cited by 25040 |
[HTML][HTML] Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2
…, EC Frias, JL Stewart, JE Van Eyk, JG Braun… - Nature medicine, 2021 - nature.com
In a cohort of BNT162b2 (Pfizer–BioNTech) mRNA vaccine recipients (n = 1,090), we observed
that spike-specific IgG antibody levels and ACE2 antibody binding inhibition responses …
that spike-specific IgG antibody levels and ACE2 antibody binding inhibition responses …
Management of patients with Crohn's disease and ulcerative colitis during the coronavirus disease-2019 pandemic: results of an international meeting
…, AN Ananthakrishnan, CN Bernstein, JG Braun… - …, 2020 - gastrojournal.org
The 2020 annual meeting for IOIBD was scheduled to occur in March, but was cancelled
owing to the emergence of COVID-19. Given how this disease might affect patients with IBD …
owing to the emergence of COVID-19. Given how this disease might affect patients with IBD …
[HTML][HTML] Gene expression profile of serial samples of transformed B-cell lymphomas
…, U Krug, M Schrage, TP Miller, JG Braun… - Laboratory …, 2003 - Elsevier
Follicular lymphoma (FL) is characterized by a continuous rate of relapse and transformation
to a high-grade lymphoma, usually diffuse large B-cell lymphoma (DLBCL), associated with …
to a high-grade lymphoma, usually diffuse large B-cell lymphoma (DLBCL), associated with …
[HTML][HTML] Prior COVID-19 infection and antibody response to single versus double dose mRNA SARS-CoV-2 vaccination
The double dose regimen for mRNA vaccines against SARS-CoV-2 presents both a hope
and a challenge for global efforts to curb the COVID-19 pandemic. With supply chain logistics …
and a challenge for global efforts to curb the COVID-19 pandemic. With supply chain logistics …
Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers: a cross-sectional study
Objective We sought to determine the extent of SARS-CoV-2 seroprevalence and the factors
associated with seroprevalence across a diverse cohort of healthcare workers. Design …
associated with seroprevalence across a diverse cohort of healthcare workers. Design …
Demographic and clinical characteristics associated with variations in antibody response to BNT162b2 COVID-19 vaccination among healthcare workers at an …
Objectives We sought to understand the demographic and clinical factors associated with
variations in longitudinal antibody response following completion of two-dose regiment of …
variations in longitudinal antibody response following completion of two-dose regiment of …
[HTML][HTML] Symptomology following mRNA vaccination against SARS-CoV-2
Despite demonstrated efficacy of vaccines against severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2), the causative agent of coronavirus disease-2019 (COVID-19), …
coronavirus-2 (SARS-CoV-2), the causative agent of coronavirus disease-2019 (COVID-19), …
[PDF][PDF] Evidence of premature lymphocyte aging in people with low anti-spike antibody levels after BNT162b2 vaccination
…, ME Modes, JE Ebinger, M Driver, JG Braun… - Iscience, 2022 - cell.com
SARS-CoV-2 vaccines have unquestionably blunted the overall impact of the COVID-19
pandemic, but host factors such as age, sex, obesity, and other co-morbidities can affect vaccine …
pandemic, but host factors such as age, sex, obesity, and other co-morbidities can affect vaccine …
[HTML][HTML] Clinical Utility of SARS-CoV-2 Serological Testing and Defining a Correlate of Protection
Herein, we review established clinical use cases for SARS-CoV-2 antibody measures,
which include diagnosis of recent prior infection, isolating high titer convalescent plasma, …
which include diagnosis of recent prior infection, isolating high titer convalescent plasma, …
SARS-CoV-2 seroprevalence across a diverse cohort of healthcare workers
Importance Antibody testing is important for understanding patterns of exposure and potential
immunity to SARS-CoV-2. Prior data on seroprevalence have been subject to variations in …
immunity to SARS-CoV-2. Prior data on seroprevalence have been subject to variations in …